Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)

Aim of investigation. Nowadays the question, whether pegylated interferon should be completely abandoned in the treatment of chronic hepatitis C (CHC) is still open. Beneficial interferon properties include: absence of mutagenic capacity for hepatitis C virus and drug interaction, stimulation of hos...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marina V. Mayevskaya, Ye. N. Bessonova, P. O. Bogomolov, N. I. Geyvandova, K. V. Zhdanov, V. G. Morozov, V. D. Pasechnikov, I. Yu. Khomenko, A. V. Yagoda, V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	хронический гепатит с лечение исследуемый препарат пегальтевир® препарат сравнения пегинтрон® эффективность безопасность
Online Access:	https://www.gastro-j.ru/jour/article/view/97
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of the first domestic pegilated interferon alpha-2b «Pegaltevir» at chronic hepatitis C: pilot data of phase III clinical study
by: V. T. Ivashkin, et al.
Published: (2014-07-01)

Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study)
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)

Diagnostics and treatment of gastroesophageal reflux disease: clinical guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

The issue of clinical application of non-invasive evaluation of liver fibrosis at chronic hepatitis B
by: Chavdar S. Pavlov, et al.
Published: (2016-08-01)

Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia
by: M. V. Sokolova, et al.
Published: (2018-08-01)

Pegilated interferon α2а in treatment of chronic hepatitis C
by: P. O. Bogomolov, et al.
Published: (2012-09-01)

The clinical role of blood coagulation and platelet receptors gene allelic variants in development of cryoglobulinemic vasculitis at chronic hepatitis C
by: Yekaterina Ye. Starostina, et al.
Published: (2018-08-01)

Infusion therapy for chronic liver diseases
by: I. A. Kurkina, et al.
Published: (2018-08-01)

Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience)
by: I. Yu. Pirogova, et al.
Published: (2018-08-01)

Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Efficacy of daclatasvir and asunaprevir for viral hepatitis С in two donor lung recipients
by: D. T. Abdurakhmanov, et al.
Published: (2018-08-01)

Diagnosis and treatment of the functional dyspepsia: clinical guidelines of the Russian Gastroenterological Association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

Helicobacter pylori infection at long-term treatment by proton pump inhibitors for acid-related diseases (Literature review and resolution of Advisory council, March 22, 2018)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Safety and efficacy of telaprevir in treatment of a chronic hepatitis C in patients of the Russian population included in early access program study
by: D. T. Abrurakhmanov, et al.
Published: (2014-07-01)

Morphological features of chronic virus-associated gastritis and duodenitis
by: S. Yu. Yermak, et al.
Published: (2018-08-01)

Seronegative autoimmune hepatitis
by: A. O. Buyeverov
Published: (2018-08-01)

Значение и особенности инвентаризации нефинансовых активов в системе обеспечения экономической безопасности учреждений правоохранительных органов
by: Марина Викторовна Феськова, et al.
Published: (2024-12-01)

Diagnostics and treatment of exocrine pancreatic insufficiency: clinical guidelines of the Russian gastroenterological Association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Diagnostics and treatment of pancreatic exocrine insufficiency: clinical guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Efficacy of pegylated interferon alfa-2b «Algeron» in the treatment of chronic hepatitis C
by: M. V. Mayevskaya, et al.
Published: (2013-03-01)

ЧЕЛОВЕК РАЗУМНЫЙ И ЧЕЛОВЕК ИСКУССТВЕННЫЙ: СОЦИАЛЬНАЯ БЕЗОПАСНОСТЬ ИЛИ ИЛЛЮЗИЯ БЕЗОПАСНОСТИ
by: Марина Теплых, et al.
Published: (2025-02-01)

Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement)
by: M. V. Maevskaya, et al.
Published: (2024-08-01)

Роль искусственного интеллекта в прогнозировании трудных дыхательных путей у взрослых: обзор литературы
by: Андрей Юрьевич Зайцев, et al.
Published: (2025-01-01)

NS5A replication complex inhibitor daclatasvir in the basis of chronic hepatitis C interferon-free therapy
by: M. V. Mayevskaya, et al.
Published: (2015-12-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Mediators of intercellular interactions and histological signs of chronic viral liver disease
by: P. V. Koroy, et al.
Published: (2014-11-01)

Prevalence and clinical aspects of Barrett’s esophagus in Khakasia republic
by: N. N. Butorin, et al.
Published: (2010-11-01)

Prevalence and risk factors of heartburn in organized population of administrative centre of Khakasia republic
by: N. N. Butorin, et al.
Published: (2010-04-01)

Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation
by: P. D. Bessonov, et al.
Published: (2018-08-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Hexapeptide dalargin in clinical gastroenterology: 30 years' of clinical application of the drug
by: S. A. Bulgakov
Published: (2016-08-01)

Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Efficacy and safety of glycyrrhizic acid and essential phospholipids (Phosphogliv) combination for alcoholic liver disease: results of the double-blind randomized placebo-controlled multicenter post-registration (phase IV) clinical trial «Jaguar» (PHG-M2/P03-12)
by: I. G. Bakulin, et al.
Published: (2018-08-01)

Evolution of copro-tests in active detection of colorectal cancer
by: V. I. Chissov, et al.
Published: (2012-11-01)

Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma
by: V. V. Petkau, et al.
Published: (2023-11-01)

Results of formation of primary and secondary smallintestinal reservoirs at ulcerative colitis
by: V. N. Kashnikov, et al.
Published: (2014-12-01)

Issues occult hepatitis B virus infection
by: I. A. Morozov, et al.
Published: (2012-07-01)